Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franziska Modemann

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
International Journal of Molecular Sciences|October 13, 2021
Mebendazole Mediates Proteasomal Degradation of GLI Transcription Factors in Acute Myeloid LeukemiaFabian Freisleben, Franziska Modemann, Jana Muschhammer, et al.
Cancers|June 10, 2022
Diagnostic Utility of Bronchoalveolar Lavage in Patients with Acute Leukemia under Broad-Spectrum Anti-Infective TreatmentSusanne Ghandili, Philipp H von Kroge, Marcel Simon, et al.
Haematologica|March 13, 2025
Plasma exchange for hyperammonemia-induced reduced consciousness after PEG-asparaginase in an adult patient with acute lymphoblastic leukemiaFelix Klingler, Anika Forstreuter, Luisa Stegat, et al.
Haematologica|June 30, 2022
Clinical features of hepatitis E infections in patients with hematologic disordersSusanne Ghandili, Cecilia Lindhauer, Sven Pischke, et al.
World Journal of Emergency Surgery : WJES|February 7, 2023
Abdominal emergency surgery in patients with hematological malignancies: a retrospective single-center analysisPhilipp H von Kroge, Anna Duprée, Oliver Mann, et al.
Leukemia|January 8, 2025
A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agentsRabia Shahswar, Razif Gabdoulline, Katja Krueger, et al.
Annals of Hematology|December 28, 2022
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapyPiroska Klement, Walter Fiedler, Razif Gabdoulline, et al.
Nature Communications|November 24, 2023
Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signaturesMelanie Schoof, Shweta Godbole, Thomas K Albert, et al.
Nature Biotechnology|March 14, 2023
Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemiaAdrian Gottschlich, Moritz Thomas, Ruth Grünmeier, et al.
Leukemia|July 21, 2025
Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysisJulian Ronnacker, Philippe J Muller, Jan-Henrik Mikesch, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
International Journal of Molecular Sciences|October 13, 2021
Mebendazole Mediates Proteasomal Degradation of GLI Transcription Factors in Acute Myeloid LeukemiaFabian Freisleben, Franziska Modemann, Jana Muschhammer, et al.
Cancers|June 10, 2022
Diagnostic Utility of Bronchoalveolar Lavage in Patients with Acute Leukemia under Broad-Spectrum Anti-Infective TreatmentSusanne Ghandili, Philipp H von Kroge, Marcel Simon, et al.
Haematologica|March 13, 2025
Plasma exchange for hyperammonemia-induced reduced consciousness after PEG-asparaginase in an adult patient with acute lymphoblastic leukemiaFelix Klingler, Anika Forstreuter, Luisa Stegat, et al.
Haematologica|June 30, 2022
Clinical features of hepatitis E infections in patients with hematologic disordersSusanne Ghandili, Cecilia Lindhauer, Sven Pischke, et al.
World Journal of Emergency Surgery : WJES|February 7, 2023
Abdominal emergency surgery in patients with hematological malignancies: a retrospective single-center analysisPhilipp H von Kroge, Anna Duprée, Oliver Mann, et al.
Leukemia|January 8, 2025
A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agentsRabia Shahswar, Razif Gabdoulline, Katja Krueger, et al.
Annals of Hematology|December 28, 2022
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapyPiroska Klement, Walter Fiedler, Razif Gabdoulline, et al.
Nature Communications|November 24, 2023
Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signaturesMelanie Schoof, Shweta Godbole, Thomas K Albert, et al.
Nature Biotechnology|March 14, 2023
Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemiaAdrian Gottschlich, Moritz Thomas, Ruth Grünmeier, et al.
Leukemia|July 21, 2025
Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysisJulian Ronnacker, Philippe J Muller, Jan-Henrik Mikesch, et al.
Pageof 2